Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access (CEPHAX)

Prospective Randomized Comparison of Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access. The CEPHAX Study.

This clinical trial evaluates the efficacy and safety of axillary versus cephalic venous access in the pacemakers and defibrillators implantation.

Half of participants will receive the implant via fluoroscopy guided axillary venous access and the other half will receive the implant via improved cephalic venous access.

Inclusion Criteria:

• Patients with a endovenous pacemaker or defibrillator indication.

Exclusion Criteria:

• Pre-existing ipsilateral pacing electrode.
• Previous ipsilateral lymphadenectomy.
• Indication of cardiac resynchronization therapy.